Guardant Health Inc (NASDAQ: GH) Is Worth A Shot If You’re A Risk-Capital Investor

In the last trading session, 1.06 million Guardant Health Inc (NASDAQ:GH) shares changed hands as the company’s beta touched 1.04. With the company’s per share price at $19.10 changed hands at $0.22 or 1.17% during last session, the market valuation stood at $2.33B. GH’s last price was a discount, traded about -114.97% off its 52-week high of $41.06. The share price had its 52-week low at $15.81, which suggests the last value was 17.23% up since then. When we look at Guardant Health Inc’s average trading volume, we note the 3-month average coming to 1.91 million.

Guardant Health Inc (NASDAQ:GH) trade information

Instantly GH was in green as seen at the end of in last trading. With action 5.00%, the performance over the past five days has been green. The jump to weekly highs of 19.63 added 1.17% to the stock’s daily price. The company’s shares are showing year-to-date downside of -29.39%, with the 5-day performance at 5.00% in the green. However, in the 30-day time frame, Guardant Health Inc (NASDAQ:GH) is 8.34% up.

Guardant Health Inc (GH) estimates and forecasts

Data shows that the Guardant Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -28.97% over the past 6 months, a 37.62% in annual growth rate that is considerably higher than the industry average of 13.00%. Year-over-year growth is forecast to reach 17.70% up from the last financial year.

Consensus estimates given by 19 financial analysts project the company’s revenue in the current quarter to hit an average of 150.67M. 18 analysts are of the opinion that Guardant Health Inc’s revenue for the current quarter will be 160.9M. The company’s revenue for the corresponding quarters a year ago was 128.71M and 137.15M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 17.10%. The estimates for the next quarter sales put growth at 17.30%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.88%. The 2024 estimates are for Guardant Health Inc earnings to increase by 22.93%, but the outlook for the next 5-year period is at 27.80% per year.